Fusion Antibodies PLC
LSE:FAB
Fusion Antibodies PLC
Change in Working Capital
Fusion Antibodies PLC
Change in Working Capital Peer Comparison
Competitive Change in Working Capital Analysis
Latest Figures & CAGR of Competitors
Company | Change in Working Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Fusion Antibodies PLC
LSE:FAB
|
Change in Working Capital
£374k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
51%
|
CAGR 10-Years
N/A
|
|
Oxford Nanopore Technologies PLC
LSE:ONT
|
Change in Working Capital
-£41.9m
|
CAGR 3-Years
-37%
|
CAGR 5-Years
-67%
|
CAGR 10-Years
N/A
|
|
O
|
Open Orphan PLC
LSE:ORPH
|
Change in Working Capital
£8.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Diaceutics PLC
LSE:DXRX
|
Change in Working Capital
£1.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
Ergomed PLC
LSE:ERGO
|
Change in Working Capital
-£4.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
hVIVO PLC
LSE:HVO
|
Change in Working Capital
£5.7m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
255%
|
CAGR 10-Years
N/A
|
See Also
What is Fusion Antibodies PLC's Change in Working Capital?
Change in Working Capital
374k
GBP
Based on the financial report for Sep 30, 2023, Fusion Antibodies PLC's Change in Working Capital amounts to 374k GBP.
What is Fusion Antibodies PLC's Change in Working Capital growth rate?
Change in Working Capital CAGR 5Y
51%
Over the last year, the Change in Working Capital growth was -48%.